Ian Clements

Ian Clements is a professional with experience in various firms.
He is currently a member of The Royal Society of Chemistry and the National Investor Relations Institute.
He has previously worked as Director-Marketing Communications at BIOVIA, Inc., Senior Director-Corporate Communications at Sequenom, Inc., Head-Investor Relations & Corporate Communications at Avanir Pharmaceuticals, Inc., VP-Investor Relations & Corporate Communications at Tobira Therapeutics, Inc., and Vice President-Investor Relations at Dermira, Inc. Currently, he is serving as the Chief Financial Officer at Mirum Pharmaceuticals, Inc. Dr. Clements holds a doctorate from The University of Manchester, an undergraduate degree from Staffordshire University, and an MBA from The Open University.